1	The	the	_	_	_	_	_	_	_
2	AP-1	ap-1	_	_	_	_	_	_	_
3	site	site	_	_	_	_	_	_	_
4	at	at	_	_	_	_	_	_	_
5	-150	-150	_	_	_	_	_	_	_
6	bp	bp	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	but	but	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	site	site	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	likely	likely	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	represent	represent	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	major	major	_	_	_	_	_	_	_
21	target	target	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	kinase	kinase	_	_	_	_	_	_	_
25	C	C	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	interleukin	interleukin	_	_	_	_	_	_	_
29	2	2	_	_	_	_	_	_	_
30	promoter	promoter	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Stimulation	stimulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	antigen	antigen	_	_	_	_	_	_	_
7	results	result	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	several	several	_	_	_	_	_	_	_
12	kinases	kinase	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	including	include	_	_	_	_	_	_	_
15	protein	protein	_	_	_	_	_	_	_
16	kinase	kinase	_	_	_	_	_	_	_
17	C	C	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	PKC	PKC	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	may	may	_	_	_	_	_	_	_
24	mediate	mediate	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	later	later	_	_	_	_	_	_	_
27	induction	induction	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	activation-related	activation-related	_	_	_	_	_	_	_
30	genes	gene	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	potential	potential	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	PKC	PKC	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	induction	induction	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	interleukin	interleukin	_	_	_	_	_	_	_
14	2	2	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	gene	gene	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	stimulated	stimulate	_	_	_	_	_	_	_
23	through	through	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	cell	cell	_	_	_	_	_	_	_
27	receptor/CD3	receptor/cd3	_	_	_	_	_	_	_
28	complex	complex	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	previously	previously	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	prolonged	prolonged	_	_	_	_	_	_	_
7	treatment	treatment	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	untransformed	untransformed	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	clone	clone	_	_	_	_	_	_	_
14	Ar-5	ar-5	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	phorbol	phorbol	_	_	_	_	_	_	_
17	esters	ester	_	_	_	_	_	_	_
18	results	result	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	downmodulation	downmodulation	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	beta	beta	_	_	_	_	_	_	_
26	isozymes	isozyme	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	PKC	PKC	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	abrogates	abrogate	_	_	_	_	_	_	_
32	induction	induction	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	IL-2	il-2	_	_	_	_	_	_	_
35	mRNA	mRNA	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	protein	protein	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	phorbol	phorbol	_	_	_	_	_	_	_
6	ester	ester	_	_	_	_	_	_	_
7	treatment	treatment	_	_	_	_	_	_	_
8	also	also	_	_	_	_	_	_	_
9	abolishes	abolish	_	_	_	_	_	_	_
10	induction	induction	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
13	acetyltransferase	acetyltransferase	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	Ar-5	ar-5	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	transfected	transfecte	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	plasmid	plasmid	_	_	_	_	_	_	_
22	containing	contain	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	IL-2	il-2	_	_	_	_	_	_	_
25	promoter	promoter	_	_	_	_	_	_	_
26	linked	link	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	this	this	_	_	_	_	_	_	_
29	reporter	reporter	_	_	_	_	_	_	_
30	gene	gene	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IL-2	il-2	_	_	_	_	_	_	_
3	promoter	promoter	_	_	_	_	_	_	_
4	contains	contain	_	_	_	_	_	_	_
5	binding	bind	_	_	_	_	_	_	_
6	sites	site	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	factors	factor	_	_	_	_	_	_	_
10	including	include	_	_	_	_	_	_	_
11	NFAT-1	nfat-1	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	Oct	Oct	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	AP-1	ap-1	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	which	which	_	_	_	_	_	_	_
22	are	be	_	_	_	_	_	_	_
23	all	all	_	_	_	_	_	_	_
24	potentially	potentially	_	_	_	_	_	_	_
25	sensitive	sensitive	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	PKC	PKC	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	induction	induction	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	trimer	trimer	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	NFAT	NFAT	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	Oct	Oct	_	_	_	_	_	_	_
13	sites	site	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	not	not	_	_	_	_	_	_	_
16	sensitive	sensitive	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	phorbol	phorbol	_	_	_	_	_	_	_
19	ester	ester	_	_	_	_	_	_	_
20	treatment	treatment	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	that	that	_	_	_	_	_	_	_
24	mutations	mutation	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	NF-kappa	NF-kappa	_	_	_	_	_	_	_
28	B	B	_	_	_	_	_	_	_
29	site	site	_	_	_	_	_	_	_
30	have	have	_	_	_	_	_	_	_
31	no	no	_	_	_	_	_	_	_
32	effect	effect	_	_	_	_	_	_	_
33	on	on	_	_	_	_	_	_	_
34	inducibility	inducibility	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	IL-2	il-2	_	_	_	_	_	_	_
38	promoter	promoter	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	mutations	mutation	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	AP-1	ap-1	_	_	_	_	_	_	_
8	site	site	_	_	_	_	_	_	_
9	located	located	_	_	_	_	_	_	_
10	at	at	_	_	_	_	_	_	_
11	-150	-150	_	_	_	_	_	_	_
12	bp	bp	_	_	_	_	_	_	_
13	almost	almost	_	_	_	_	_	_	_
14	completely	completely	_	_	_	_	_	_	_
15	abrogate	abrogate	_	_	_	_	_	_	_
16	induction	induction	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	IL-2	il-2	_	_	_	_	_	_	_
20	promoter	promoter	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	appearance	appearance	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	an	an	_	_	_	_	_	_	_
26	inducible	inducible	_	_	_	_	_	_	_
27	nuclear	nuclear	_	_	_	_	_	_	_
28	factor	factor	_	_	_	_	_	_	_
29	binding	bind	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	this	this	_	_	_	_	_	_	_
32	site	site	_	_	_	_	_	_	_
33	is	be	_	_	_	_	_	_	_
34	sensitive	sensitive	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	PKC	PKC	_	_	_	_	_	_	_
37	depletion	depletion	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	cotransfections	cotransfection	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	c-fos	c-fos	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	c-jun	c-jun	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	plasmids	plasmid	_	_	_	_	_	_	_
10	markedly	markedly	_	_	_	_	_	_	_
11	enhance	enhance	_	_	_	_	_	_	_
12	induction	induction	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	promoter	promoter	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	minimally	minimally	_	_	_	_	_	_	_
19	stimulated	stimulate	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	AP-1	ap-1	_	_	_	_	_	_	_
7	site	site	_	_	_	_	_	_	_
8	at	at	_	_	_	_	_	_	_
9	-150	-150	_	_	_	_	_	_	_
10	bp	bp	_	_	_	_	_	_	_
11	represents	represent	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	major	major	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	if	if	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	only	only	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	site	site	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	PKC	PKC	_	_	_	_	_	_	_
23	responsiveness	responsiveness	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	IL-2	il-2	_	_	_	_	_	_	_
27	promoter	promoter	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

